If scientists want to boost immune cells' ability to kill cancer cells, then vast libraries of small molecules are potentially available. A new paper shows a platform to sort through them, plus validation. One of the hits: IAP antagonist birinapant, which is already in clinical trials (coincidentally).
from Top Technology News -- ScienceDaily https://www.sciencedaily.com/releases/2019/01/190110113002.htm
from Top Technology News -- ScienceDaily https://www.sciencedaily.com/releases/2019/01/190110113002.htm
Comments
Post a Comment
Thank you for your message. We are improving our services everyday.